Literature DB >> 15000560

A prospective epidemiological survey of candidaemia in Sweden.

Lena Klingspor1, Ewa Törnqvist, Anders Johansson, Björn Petrini, Urban Forsum, Göran Hedin.   

Abstract

A prospective epidemiological survey of candidaemia was performed in central Sweden from January 1998 to December 1999. In total, 191 episodes were reported with an overall rate of 0.32/1000 admissions. Candida albicans was identified in 128 cases (67%), followed by Candida glabrata in 30 (15.7%) and Candida parapsilosis in 14 (7.3%). Predisposing factors included surgery (31.4%), intensive care (18.8%), solid tumour or haematological malignancy (15.7%), and foetal immaturity (15.7%). Non-albicans Candida species were more prevalent among patients with haematological malignancies (56%), compared to surgical (30%) and ICU patients (19%). The crude mortality rate of candidaemia was 31%. The highest mortality rate was observed in patients with haematological malignancies (41.2%), age > 70 y (41%), surgery (38.5%) and infections with > 1 Candida species (40%) or C. glabrata (38%).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15000560     DOI: 10.1080/00365540310017447

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  10 in total

1.  Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility.

Authors:  Maiken Cavling Arendrup; Kurt Fuursted; Bente Gahrn-Hansen; Irene Møller Jensen; Jenny Dahl Knudsen; Bettina Lundgren; Henrik C Schønheyder; Michael Tvede
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

2.  National surveillance of fungemia in Denmark (2004 to 2009).

Authors:  Maiken Cavling Arendrup; Brita Bruun; Jens Jørgen Christensen; Kurt Fuursted; Helle Krogh Johansen; Poul Kjaeldgaard; Jenny Dahl Knudsen; Lise Kristensen; Jens Møller; Lene Nielsen; Flemming Schønning Rosenvinge; Bent Røder; Henrik Carl Schønheyder; Marianne K Thomsen; Kjeld Truberg
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

3.  Global trends in candidemia: review of reports from 1995-2005.

Authors:  Juliette Morgan
Journal:  Curr Infect Dis Rep       Date:  2005-11       Impact factor: 3.725

4.  Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?

Authors:  Rafael Zaragoza; Javier Pemán; Miguel Salavert; Angel Viudes; Amparo Solé; Isidro Jarque; Emilio Monte; Eva Romá; Emilia Cantón
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

5.  Clinical characteristics and risk factors for nosocomial candidemia in medical intensive care units: experience in a single hospital in Korea for 6.6 years.

Authors:  Seon-Sook Han; Jae-Joon Yim; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Young-Soo Shim; Sang-Min Lee
Journal:  J Korean Med Sci       Date:  2010-04-16       Impact factor: 2.153

6.  Characterization of biofilm formation and the role of BCR1 in clinical isolates of Candida parapsilosis.

Authors:  Srisuda Pannanusorn; Bernardo Ramírez-Zavala; Heinrich Lünsdorf; Birgitta Agerberth; Joachim Morschhäuser; Ute Römling
Journal:  Eukaryot Cell       Date:  2013-12-02

7.  Economic considerations of antifungal prophylaxis in patients undergoing surgical procedures.

Authors:  Maria Adriana Cataldo; Nicola Petrosillo
Journal:  Ther Clin Risk Manag       Date:  2011-01-13       Impact factor: 2.423

Review 8.  Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit.

Authors:  Matteo Bassetti; Malgorzata Mikulska; Claudio Viscoli
Journal:  Crit Care       Date:  2010-12-01       Impact factor: 9.097

9.  Estimating the Burden of Serious Fungal Infections in Uruguay.

Authors:  Marina Macedo-Viñas; David W Denning
Journal:  J Fungi (Basel)       Date:  2018-03-18

10.  Epidemiological trends in nosocomial candidemia in intensive care.

Authors:  Matteo Bassetti; Elda Righi; Alessandro Costa; Roberta Fasce; Maria Pia Molinari; Raffaella Rosso; Franco Bobbio Pallavicini; Claudio Viscoli
Journal:  BMC Infect Dis       Date:  2006-02-10       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.